A few lucky plant biologists are about to receive admittance to one of the most elite biomedical clubs in the United States: the Howard Hughes Medical Institute (HHMI). HHMI and the Gordon and Betty Moore Foundation announced today that they have teamed up to make a $75 million contribution to the plant sciences by supporting up to 15 plant researchers. Read more
Posted on behalf of Yana Balling Amyris Inc, a start-up biotech company specialising in biofuels, raised $85 million in its first public offering yesterday. An estimated 5.3 million shares were sold throughout the day on the NASDAQ Global Market. The company, based in Emeryville, California, had hoped to raise $100 million. Analysts ascribe the disappointing performance to Amyris entering the market too early, before it has commercialised any of its renewable products. But Biofuels Digest declared the glass half-full, saying that the money raised was a ‘hallmark of faith’ in the potential of biofuel technology. Amyris, now with 200 employees, … Read more
Here’s a surprising reversal of roles: drug giant Pfizer is accusing the open access journal PLoS Medicine of failing to disclose a financial conflict of interest.
Swiss food giant Nestlé said on Monday that it would invest 500 million Swiss francs (US$507 million) over ten years in an Institute of Health Sciences currently being built at the Swiss Federal Institute of Technology (EPFL) in Lausanne, where the company (based in Vevey) already endows research chairs.
The 19 African nations, including Uganda and Egypt, that are members of the Common Market for Eastern and Southern Africa (COMESA) – a free trade zone – have begun consulting on plans to harmonise their polices and guidelines on the commercial planting and trade in genetically modified crops.